AZN Astrazeneca PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AZN
- PE Ratio
The current PE ratio for Astrazeneca stock as of Jun 24, 2025 is 28.1. This is calculated based on the TTM EPS of $2.51 and the stock price of $70.54 per share. The PE ratio marks a decrease of 15% from its last 4 quarters average of 33.2.
AZN PE ratio history
The average historical PE ratio of Astrazeneca for the last ten years is 81.35. The current P/E ratio of 28.1 is 65% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $58.25 and the EPS was $0.04. The lowest point was in the Dec 2016 quarter, when it reached 19.65 with a price of $27.32 and an EPS of $1.39.
Astrazeneca PE ratio by year
Maximum annual increase: 3,453.56% in 2021
Maximum annual decrease: -95.61% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 28.86 | -17.73% | $65.52 | $2.27 |
| 2023 | 35.08 | -45.15% | $67.35 | $1.92 |
| 2022 | 63.96 | -95.61% | $67.8 | $1.06 |
| 2021 | 1,456.25 | 3,453.56% | $58.25 | $0.04 |
| 2020 | 40.98 | -57.26% | $49.99 | $1.22 |
| 2019 | 95.88 | 114.59% | $49.86 | $0.52 |
| 2018 | 44.68 | 53.22% | $37.98 | $0.85 |
| 2017 | 29.16 | 48.4% | $34.7 | $1.19 |
| 2016 | 19.65 | -35.17% | $27.32 | $1.39 |
| 2015 | 30.31 | -57.8% | $33.95 | $1.12 |
| 2014 | 71.82 | 146.8% | $35.19 | $0.49 |
| 2013 | 29.1 | 205.35% | $29.69 | $1.02 |
| 2012 | 9.53 | 50.32% | $23.64 | $2.48 |
| 2011 | 6.34 | -23.15% | $23.15 | $3.65 |
| 2010 | 8.25 | -8.64% | $23.1 | $2.8 |
Astrazeneca PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 29.28 | 1.46% | $73.5 | $2.51 |
| Dec 2024 | 28.86 | -22.21% | $65.52 | $2.27 |
| Sep 2024 | 37.1 | -1.07% | $77.91 | $2.1 |
| Jun 2024 | 37.5 | 13.46% | $77.99 | $2.08 |
| Mar 2024 | 33.05 | -5.79% | $67.75 | $2.05 |
| Dec 2023 | 35.08 | -1.57% | $67.35 | $1.92 |
| Sep 2023 | 35.64 | -0.89% | $67.72 | $1.9 |
| Jun 2023 | 35.96 | -21.24% | $71.57 | $1.99 |
| Mar 2023 | 45.66 | -28.61% | $69.41 | $1.52 |
| Dec 2022 | 63.96 | -34.69% | $67.8 | $1.06 |
| Sep 2022 | 97.93 | N/A | $54.84 | $0.56 |
| Jun 2022 | N/A | N/A | $66.07 | -$0.53 |
| Mar 2022 | N/A | N/A | $66.34 | -$0.43 |
| Dec 2021 | 1,456.25 | 1,476.03% | $58.25 | $0.04 |
| Sep 2021 | 92.4 | 122.12% | $60.06 | $0.65 |
AZN Price vs fair value
AZN average PE ratio chart
Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.
AZN PE vs peers
In comparison to its peer LLY, AZN's PE ratio is lower, but it is higher than JNJ's and ABT's. Astrazeneca's PE ratio is trading above the peer average of 21.92.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.58 | $200.43B |
| BIIB Biogen Inc | 12.5 | $18.61B |
| JNJ Johnson & Johnson | 16.8 | $366.2B |
| BMY Bristol Myers Squibb Co | 17.43 | $95.04B |
| PFE Pfizer Inc | 17.46 | $137.98B |
| ABT Abbott Laboratories | 17.87 | $239.98B |
| NVS Novartis AG | 18.32 | $231.18B |
| AZN Astrazeneca plc | 27.76 | $216.04B |
| LLY ELI LILLY & Co | 64.21 | $750.89B |
Frequently asked questions
What is Astrazeneca's PE ratio?
AZN stock has a price to earnings ratio of 28.1 as of Jun 24, 2025.
What is the 3-year average PE ratio for Astrazeneca (AZN)?
The 3-year average price to earnings ratio for AZN stock is 43.64.
What is the 5-year average PE ratio for Astrazeneca (AZN)?
The 5-year average price to earnings ratio for AZN stock is 125.9.
What is the highest PE ratio for AZN?
Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.
How does the current PE ratio for AZN compare to its historical average?
The current PE ratio of AZN is 65% lower than the 10-year historical average.
How is AZN's PE ratio calculated (Astrazeneca PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 24, 2025), Astrazeneca's share price is $70.54. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $2.51. Therefore, Astrazeneca's PE ratio for today is 28.1. PE RATIO(28.1) = STOCK PRICE($70.54) / TTM EPS($2.51)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.